跳至主要内容
临床试验/NCT02467894
NCT02467894已完成不适用

Group-based Chronic Kidney Disease Care

Albert Einstein College of Medicine2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Blood pressure control

研究概览

简要总结

A two-group randomized clinical trial testing whether group-based care is feasible and will help improve blood pressure control in adult and adolescent patients with chronic kidney disease and hypertension.

详细描述

This two-group RCT will enroll 100 subjects, adolescents over or equal to 12 years of age, and men and women over age of 21, with stage 3-4 and 5 CKD from various causes including diabetes and hypertension. Patients will be recruited from the Montefiore Medical Center Nephrology. The primary aim will be to assess feasibility of the intervention.

Informed consent will be obtained on all subjects. All subjects with meet with one of the investigators who will verbally explain to them the purpose of the study and the alternatives.

Blood and 24 hr urine test will be collected to assess for sodium, phosphorus, and serum creatinine. These tests will be used for experimental purposes only and will be collected at enrollment and 6 months visit.

There will be two arms, an arm randomized to Group-based care attending monthly outpatient clinic visits as part of a group and the other to usual care who will see their provider once a month for 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adolescent Age ≥12 years old
  • Sufficient hearing, vision, and proficiency in English or Spanish to comprehend low- literacy printed educational materials and participate in group sessions (assessed by provider)
  • Adult: (¬>21 years): Systolic blood pressure >140 at two clinic visits in the past year or >160 at one visit and Adolescent: (12-21 years) systolic blood pressure >95 percentile (based on sex and age) at 2 clinic visits in the past year
  • For adults: Stage 3-5 CKD (eGFR<60 ml/min/1.73m2)
  • For adolescents: evidence of kidney damage (albuminuria, congenital anomalies of the kidney or urinary tract) and hypertension
  • Prescription for anti-hypertensive medication (in adults)
  • Unwillingness to accept random assignment
  • Unwillingness to provide informed consent

排除标准

  • Transplanted organ
  • Rapidly deteriorating kidney function with the expectation for initiation of dialysis in less than 6 months
  • Plans to relocate out of New York City in the next 6 months

研究组 & 干预措施

Group-based Care

Experimental

Participants who are randomized to group-based care will attend monthly outpatient clinic visits as part of a group of 8-10 patients with CKD and hypertension.

干预措施: Group-based Care (Other)

Usual Care

No Intervention

Participants who are randomized to usual care will see their provider on clinic days when there is no group meeting.

结局指标

主要结局

Blood pressure control

时间窗: 6 months

The primary outcome will be blood pressure control (mean SBP \<140 mmHg) as measured by 24-hour ambulatory blood pressure monitor.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michal L. Melamed

Associate Professor Of Medicine & Epidemiology & Population Health

Albert Einstein College of Medicine

研究点 (2)

Loading locations...

相似试验